Vimarsana
Biggest News Aggregation in the World

Page 14 - Nasdaq Pcvx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Pcvx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Pcvx Today - Breaking & Trending Today

Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) VP Sells 5,000 Shares of Stock - Vimarsana News

Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) VP Sells 5,000 Shares of Stock

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) VP Jeff Fairman sold 5,000 shares of the business’s stock in a transaction on Tuesday, April 5th. The shares were sold at an average price of $25.59, for a total value of $127,950.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is […]

Vaxcyte (NASDAQ:PCVX) Shares Gap Up to $25.68 - Vimarsana News

Vaxcyte (NASDAQ:PCVX) Shares Gap Up to $25.68

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $25.68, but opened at $26.55. Vaxcyte shares last traded at $26.38, with a volume of 1,109 shares traded. Several research firms have recently commented on PCVX. Zacks Investment Research downgraded shares of […]

Vaxcyte, Inc. (NASDAQ:PCVX) SVP Sells $150,000.00 in Stock - Vimarsana News

Vaxcyte, Inc. (NASDAQ:PCVX) SVP Sells $150,000.00 in Stock

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) SVP Paul Sauer sold 6,000 shares of Vaxcyte stock in a transaction dated Thursday, March 10th. The shares were sold at an average price of $25.00, for a total value of $150,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be […]

Equities Analysts Offer Predictions for Vaxcyte, Inc.'s FY2022 Earnings (NASDAQ:PCVX) - Vimarsana News

Equities Analysts Offer Predictions for Vaxcyte, Inc.'s FY2022 Earnings (NASDAQ:PCVX)

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) – Equities researchers at Jefferies Financial Group lowered their FY2022 earnings estimates for shares of Vaxcyte in a report issued on Monday, February 28th. Jefferies Financial Group analyst R. Song now forecasts that the company will post earnings per share of ($2.38) for the year, down from their previous […]

Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its - Vimarsana News

Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its

FOSTER CITY, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health...